The levels of expression of PHD1-3 have been determined in the same set of samples earlier [21], and similarly to high p16 expression, high PHD2 expression had a tendency to promote breast cancer-specific survival and disease-free survival [21]. This evidence concerns the gene CDKN2A and breast carcinoma.